[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

DelveInsight: Market Research Reports

DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:

  • Company’s profile and licensing data;
  • New technology studies;
  • Biologic benchmarking;
  • Treatment modality analysis;
  • Competitive landscape;
  • Product assessment; etc.


This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.

DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.

Publications found: 6,889
Sort by:

Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Insight, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Vancomycin-Resistant Enterococcus Faecium Infections The report also ...

January 2020 60 pages

Vasomotor Symptoms of Menopause - Pipeline Insight, 2020

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Vasomotor Symptoms of Menopause The report also ...

January 2020 90 pages

Venous Leg Ulcers - Pipeline Insight, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Venous Leg Ulcers The report also ...

January 2020 90 pages

Venous Thromboembolism - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Venous Thromboembolism - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Venous Thromboembolism development. The report provides ...

January 2020 60 pages

Ventilator Associated Pneumonia (VAP) - Pipeline Insight, 2020

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Ventilator Associated Pneumonia (VAP) The report also ...

January 2020 60 pages

Waldenstrom Macroglobulinemia - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Waldenstrom Macroglobulinemia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Waldenstrom Macroglobulinemia development. The report provides ...

January 2020 60 pages

B-Cell Chronic Lymphocytic Leukemia - Pipeline Insight, 2020

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for B-Cell Chronic Lymphocytic Leukemia The report also ...

January 2020 60 pages

B-Cell Lymphomas - Pipeline Insight, 2020

US$ 2,000.00

... clients within 5 Days 'B-Cell Lymphomas - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across B-Cell Lymphomas development. The report provides ...

January 2020 60 pages

B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2020

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for B-Cell Non-Hodgkin Lymphoma The report also ...

January 2020 60 pages

Chikungunya - Pipeline Insight, 2020

US$ 1,500.00

... clients within 72 Hours 'Chikungunya - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Chikungunya development. The report provides detailed ...

January 2020 60 pages

Chlamydia Infections - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Chlamydia Infections - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Chlamydia Infections development. The report provides ...

January 2020 60 pages

Cutaneous T- Cell Lymphoma (CTCL) - Market Insights, Epidemiology and Market Forecast-2028

US$ 3,250.00

... (CTCL) Pipeline Analysis Cutaneous T-Cell Lymphoma(CTCL) Market Size and Trends Cutaneous T-Cell Lymphoma(CTCL) Market Opportunities Impact of upcoming Therapies in Cutaneous T-Cell Lymphoma(CTCL) Cutaneous T-Cell Lymphoma(CTCL) Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation ...

January 2020 189 pages

Endometriosis- Pipeline Insights, 2020

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Endometriosis- Pipeline Insight, 2019 The report also ...

January 2020 60 pages

Human Papillomavirus Associated Diseases - Pipeline Insights, 2020

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Human Papillomavirus Associated Diseases - Pipeline Insight, 2019 The ...

January 2020 60 pages

Narcolepsy-Pipeline Insights, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Narcolepsy-Pipeline Insight, 2019 The report also ...

January 2020 60 pages

West Nile - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'West Nile - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across West Nile development. The report provides ...

January 2020 60 pages

Insulin Resistance - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

US$ 2,000.00

... marketed and Phase III products for Insulin Resistance. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Insulin Resistance - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours ' Insulin Resistance - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Insulin Resistance development. The report provides ...

January 2020 60 pages

Pruritus - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

US$ 2,000.00

... marketed and Phase III products for Pruritus. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Synovial Sarcoma - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours ' Synovial Sarcoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Synovial Sarcoma development. The report provides ...

January 2020 60 pages

Varicella Zoster (HHV-3) Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

US$ 2,000.00

... marketed and Phase III products for Varicella Zoster (HHV-3) Infections. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Acne Vulgaris - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

US$ 2,000.00

... marketed and Phase III products for Acne Vulgaris. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 150 pages

Acromegaly - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

US$ 2,000.00

... marketed and Phase III products for Acromegaly. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Actinic Keratosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

US$ 2,000.00

... marketed and Phase III products for Actinic Keratosis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 120 pages

Acute Coronary Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

US$ 2,000.00

... marketed and Phase III products for Acute Coronary Syndrome. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 120 pages

Allergic Conjunctivitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

US$ 2,000.00

... marketed and Phase III products for Allergic Conjunctivitis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Allergic Rhino-Conjunctivitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

US$ 2,000.00

... marketed and Phase III products for Allergic Rhino-Conjunctivitis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Alopecia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

US$ 2,000.00

... marketed and Phase III products for Alopecia. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Anal Fissure - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Anal Fissure - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Anal Fissure development. The report provides ...

January 2020 60 pages

Anesthetic Effect - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

US$ 2,000.00

... marketed and Phase III products for Anesthetic Effect. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Anorexia Nervosa - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Anorexia Nervosa - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Anorexia Nervosa development. The report provides ...

January 2020 60 pages

Anterior Uveitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

US$ 2,000.00

... marketed and Phase III products for Anterior Uveitis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Anterior Uveitis - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Anterior Uveitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Anterior Uveitis development. The report provides ...

January 2020 60 pages

Aplastic Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

US$ 2,000.00

... marketed and Phase III products for Aplastic Anemia. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Ascites - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Ascites - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Ascites development. The report provides detailed ...

January 2020 60 pages

Aspergillosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

US$ 2,000.00

... marketed and Phase III products for Aspergillosis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Athlete's Foot (Tinea Pedis) - Pipeline Insight, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Athlete's Foot (Tinea Pedis) The report also ...

January 2020 120 pages

Autism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

US$ 2,000.00

... marketed and Phase III products for Autism. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Bacteremia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

US$ 2,000.00

... marketed and Phase III products for Bacteremia. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Bacterial (Pyogenic) Meningitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

US$ 2,000.00

... marketed and Phase III products for Bacterial (Pyogenic) Meningitis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Bacterial Pneumonia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

US$ 2,000.00

... marketed and Phase III products for Bacterial Pneumonia. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Bacterial Vaginosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

US$ 2,000.00

... marketed and Phase III products for Bacterial Vaginosis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

B-Cell Chronic Lymphocytic Leukemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

US$ 2,000.00

... marketed and Phase III products for B-Cell Chronic Lymphocytic Leukemia. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

B-Cell Lymphomas - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

US$ 2,000.00

... marketed and Phase III products for B-Cell Lymphomas. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 150 pages

Behcet's Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

US$ 2,000.00

... marketed and Phase III products for Behcet's Disease. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Biliary Tumor - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

US$ 2,000.00

... marketed and Phase III products for Biliary Tumor. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Bipolar Disorder (Manic Depression) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

US$ 2,000.00

... marketed and Phase III products for Bipolar Disorder (Manic Depression). The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 60 pages

Birch Pollen Allergy - Pipeline Insight, 2020

US$ 1,250.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Birch Pollen Allergy The report also ...

January 2020 120 pages

Blepharitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

US$ 2,000.00

... marketed and Phase III products for Blepharitis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country. Global API Manufacturers of Marketed ...

January 2020 40 pages

Cervical Dysplasia - Pipeline Insight, 2020

US$ 1,250.00

... clients within 48 Hours 'Cervical Dysplasia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Cervical Dysplasia development. The report provides ...

January 2020 60 pages

Filters

Search

Categories

5,477
618
651
143

Publishers

6,889

Regions

6,889

Price

Date

Pages

Offers